An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone on a forum shared that they started Wegovy (a brand of semaglutide) and went from 183 to about 161 pounds — roughly 22 pounds — which averages to about 1.5 pounds per week. They say the biggest drop happened in the first month at the lowest dose, and now the pace feels slower. They’re asking if that slowdown is normal and what other people’s experiences have been. Semaglutide is the active drug in Wegovy and Ozempic. It’s a man-made version of a natural hormone your gut makes after you eat. That hormone talks to your brain and helps you feel full, so you naturally eat less. It also slows how fast your stomach empties, which can help reduce hunger spikes. Doctors prescribe different doses over time so your body adjusts and side effects are manageable. What this post actually shows is a single-person experience — an anecdote, not a controlled study. Losing 22 pounds over a few months is a meaningful amount, and averaging 1.5 pounds per week is within what many weight-loss plans consider a steady pace. It’s common for weight loss to be faster at the start and then slow down. Early losses often include water weight and glycogen (the quick energy stored in muscles), which come off quickly when you eat less. After that initial phase, fat loss tends to proceed more slowly and unevenly. The post doesn’t tell us about their calorie intake, activity level, exact timeline, or other health factors, so we can’t generalize beyond “this person is losing weight but noticing a slowdown.” Why this matters: if you or someone you know is on Wegovy, this is a familiar pattern. Early rapid changes can feel motivating, and a slowdown can feel frustrating or worrying. Knowing the slowdown is common helps set realistic expectations. It also signals when to check in with a clinician: if weight stalls completely for a long time, you might look at dose, diet, exercise, sleep, stress, or other medications. For people using semaglutide to manage weight or related conditions, monitoring trends rather than day-to-day numbers gives a healthier picture of progress. Caveats and risks: semaglutide has side effects like nausea, diarrhea, constipation, and sometimes more serious issues (rare) such as gallbladder problems or changes in blood sugar. It’s a prescription medication — don’t adjust dose or stop it without talking to your doctor. Also, long-term weight maintenance often requires behavioral changes (diet, exercise, sleep) alongside medication; stopping the drug can lead to weight regain for some people. Finally, a single forum post is anecdote, not evidence; population-level studies show average effects, but individuals vary. Bottom line: a faster drop early on followed by a slower, steadier pace is common with Wegovy — it can be normal, but keep your care team in the loop if you’re concerned.
Source: r/Semaglutide